Please login to the form below
COPD
This page shows the latest COPD news and features for those working in and with pharma, biotech and healthcare.
ABPI and AHSN Network targets NHS biomedical innovations uptake
AHSN Network chair Mike Hannay. This specific collaboration encouraged the progression of three projects in Hepatitis C, COPD and mental health all in its first year of operation.
Latest news
-
Boehringer’s Corsico to be new GSK drug dev leader
However the company has just received bad news from the FDA, the US regulator refusing to approval a licence extension for its respiratory drug Nucala into COPD, citing i nsufficient efficacy
-
AZ prepares to file COPD triple, taking on rival GSK
AZ prepares to file COPD triple, taking on rival GSK. Latest salvo in combination trials competition. ... AstraZeneca has said it is ready to file for approval of its chronic obstructive pulmonary disease (COPD) triple therapy before the end of the year,
-
FDA rejects GSK’s Nucala for COPD
FDA rejects GSK’ s Nucala for COPD. Says evidence that Nucala was effective in preventing COPD exacerbations was insufficient. ... Meanwhile, Nucala isn’t the first drug in the IL-5 inhibitor class to run into trouble in COPD.
-
FDA rejects GSK’s Nucala for COPD
FDA rejects GSK’ s Nucala for COPD. Decision will add to slow growth for respiratory newcomer. ... Meanwhile, Nucala isn’t the first drug in the IL-5 inhibitor class to run into trouble in COPD.
-
AZ, Amgen’s first-in-class asthma drug gets breakthrough status
for severe asthma in Europe in January but just failed a test in chronic obstructive pulmonary disease (COPD).
More from news
Approximately 77 fully matching, plus 233 partially matching documents found.
Latest Intelligence
-
AstraZeneca: building a new ‘open innovation’ pharma company
AstraZeneca launched five significant new medicines in 2017: immunotherapy Iminzi, Calquence for mantle cell lymphoma, Qtern in type 2 diabetes, Bevespi Aerosphere in COPD and Fasenra for severe asthma.
-
Open minds for open innovation
And a couple of years ago, Novartis and the COPD Foundation’s crowd-shaped project won Communique’s Innovation in Healthcare Communications Award!
-
Significant figures
NTM is a rare progressive, destructive infection that’s normally found in addition to pulmonary diseases such as chronic obstructive pulmonary disease (COPD), cystic fibrosis or bronchiectasis.
-
The good, the bad and the ugly
Its revenues grew by a further 9% last year. “A large percentage of this growth was driven by Ellipta, but Nucala - a biologic approved for asthma and COPD - also played its ... The category has also seen the recent introduction of a major drug class
-
Asthma: beyond the blue and the brown
Combine asthma with other respiratory diseases, including chronic obstructive pulmonary disease (COPD), and it contributes to more than 4 million deaths every single year, a stagnated figure that has seen no ... This year, Circassia established a
More from intelligence
Approximately 0 fully matching, plus 32 partially matching documents found.
Latest appointments
-
Vikas Sinha joins Verona as non-executive director
A potential first-in-class treatment for chronic obstructive pulmonary disease (COPD), Verona Pharma's RPL554 is being tested as a nebulised maintenance treatment for patients with moderate to severe disease.
-
GSK's Dr Brett Haumann takes up chief medical officer role at Circassia
Most recently these saw him serve as VP and medicines development leader responsible for the late-stage development of once-daily inhaled medicines for asthma and chronic obstructive pulmonary disease (COPD).
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Raising Awareness: It’s World COPD Day today!
and education events.Raising awareness of COPD is an important part of COPD day. ... Inhaled corticosteroids (ICS) are another COPD treatment used to reduce inflammation in the lungs.
-
Using mobile “diary” research to capture patient-generated insights in COPD
Our latest case study demonstrates how a mobile app methodology was used to deliver key insights into issues faced by COPD patients. ... Using this approach, we believed our clients could better understand the issues faced by patients, which would help
-
WE’s Make Twitter #COUGH campaign awarded with PM Society Bronze
3 May 2016 (London) – WE’ s “ Make Twitter #COUGH” campaign for World COPD Day has been recognized at this year’ s PM Society Digital Awards. “ ... Make Twitter #COUGH” was a unique awareness day campaign designed to shine a light on a key
-
Big wins for Frontera at the 2016 PM Awards
This provides healthcare professionals with a life-action experience of what COPD patients go through on a daily basis.
-
Telehealth Research
Telehealth services are being used by more and more patients with chronic diseases such as asthma, COPD, diabetes and cardiovascular disease.
More from PMHub
Approximately 1 fully matching, plus 15 partially matching documents found.
Featured jobs
-
Associate Medical Director
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 benefits
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
-
Senior Account Manager - Med Comms
-
Highly Competitive Salary &Benefits
-
Associate Medical Director
-
Highly Competitive
- Experienced Editor, London, Medical Communications
-
Competitive package
- Account Director – Global Healthcare PR
-
Salary TBC
- Director Healthcare PR Communications
-
Salary TBC
- Account Manager, Healthcare Advertising
-
Salary TBC
-
Account Director - Digital
-
Great salary and benefits
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
-
Account Director
-
Negotiable
-
Scientific Team Lead
-
Competitive Salary
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
-
Scientific Director
-
Highly Competitive Salary &Benefits
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Lead Medical Copywriter, Healthcare Brand Communications, London
-
Excellent package
- Senior Account Manager / Account Director - Med Comms
-
Great salary and benefits
Subscribe to our email news alerts
- Shire’s angioedema drug Takhzyro recommended in Europe
- Cuttsy+Cuttsy launch their latest patient e-book
- McCann Health London launch Urban Eye Test
- Encouraging data for GenSight’s blinding retinal disease gene therapy
- Keytruda hits survival targets in first-line kidney cancer
- UK ‘unicorn’ Oxford Nanopore bags $65m backing from Amgen
PMHub
PharmiWeb Solutions
PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...
Latest intelligence
- Retaining reader value in plain language summaries of clinical studies
- Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
- Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
- Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
- Making Europe a leader in bioscience: boosting trust and opening minds
- A vision of Paris as Europe's leading hub for life sciences innovation...
Quick links
Infographics
